Versuchen GOLD - Frei
Corona Remedies acquires Wokadine from DR Reddy's Laboratories
M & A Critique
|April 2026
Corona Remedies announced the acquisition of the Wokadine brand from Dr. Reddy's Laboratories to strengthen its presence in targeted specialty segment and offer wider accessibility.
-
The Wokadine brand is an antiseptic and disinfectant containing Povidone-lodine, used to treat or prevent skin infections in minor cuts, burns, wounds, and abrasions.
Diese Geschichte stammt aus der April 2026-Ausgabe von M & A Critique.
Abonnieren Sie Magzter GOLD, um auf Tausende kuratierter Premium-Geschichten und über 9.000 Zeitschriften und Zeitungen zuzugreifen.
Sie sind bereits Abonnent? Anmelden
WEITERE GESCHICHTEN VON M & A Critique
M & A Critique
Austria's Raiffeisen to buy BBVA's Romania unit for $680 million
Austria's Raiffeisen Bank said it would buy Garanti BBVA's Romanian business for 591 million euros [$680 million), its first significant acquisition in recent years.
1 min
April 2026
M & A Critique
Corona Remedies acquires Wokadine from DR Reddy's Laboratories
Corona Remedies announced the acquisition of the Wokadine brand from Dr. Reddy's Laboratories to strengthen its presence in targeted specialty segment and offer wider accessibility.
1 min
April 2026
M & A Critique
Euro Pratik Sales acquires majority stake in Chawla Brothers
Euro Pratik Sales announced the acquisition of a 51% stake in Chawla Brothers, a well-established decorative surfaces business in North India.
1 min
April 2026
M & A Critique
NCLAT reverses insolvency proceedings against Vatika Ltd
NCLAT has reversed the National Company Law Tribunal (NCLT) order of initiation of insolvency proceedings against Gurgaon-based real estate developer Vatika Ltd.
1 min
April 2026
M & A Critique
PGCIL board nod to new merger plan for 28 subsidiaries
The board of Power Grid Corporation of India Ltd has approved a revised plan to consolidate its subsidiary structure, paving the way for the merger of 28 wholly owned subsidiaries into two other group entities, according to a regulatory filing.
1 min
April 2026
M & A Critique
Corporate Law - Reforms and Regulatory Amendments 2026 - Proposed
The Corporate Laws (Amendment) Bill, 2026, introduced in the Lok Sabha on March 18, 2026, proposes several significant changes to both the Companies Act, 2013 and the Limited Liability Partnership (LLP) Act, 2008.
6 mins
April 2026
M & A Critique
GAIL to acquire 49% stake in Leafiniti Bioenergy (arm of TruAlt Bioenergy)
TruAlt Bioenergy today announced a strategic investment of Rs 13 crore by GAIL (India) in its subsidiary, Leafiniti Bioenergy (LBPL), marking a significant step in advancing its Compressed Biogas (CBG) portfolio and strengthening its role in India's energy transition.
1 mins
April 2026
M & A Critique
Varun Beverages to acquire South African firm Crickley Dairy
Varun Beverages said its South African subsidiary Bevco will acquire Crickley Dairy Proprietary for Rs 131.47 crore.
1 min
April 2026
M & A Critique
Mastercard explores sale of payments unit it bought from Nets in 2019, FT reports
Mastercard is seeking to sell the real-time payments unit that it acquired from Denmark's Nets Group in 2019 for $3.2 billion, the Financial Times reported, citing people familiar with the matter.
1 min
April 2026
M & A Critique
Adani Enterprises gets NCLT nod for JAL takeover
The National Company Law Tribunal (NCLT) has approved the acquisition of Jaiprakash Associates Ltd (JAL) by Adani Enterprises, clearing the way for one of the most high-profile resolutions under India's insolvency framework.
1 mins
April 2026
Listen
Translate
Change font size